Sparsentan superior to irbesartan in focal segmental glomerulosclerosis patients, reveals DUPLEX trial Dr Kartikeya Kohli22 May 2024 8:30 AM ISTUSA: A groundbreaking clinical trial, known as the DUPLEX trial, has unveiled promising results in treating Focal Segmental Glomerulosclerosis (FSGS),...
New study identifies five ferroptosis-related genes which may be a novel therapeutic target for focal segmental glomerulosclerosis Medha Baranwal29 Feb 2024 2:00 AM ISTChina: Ferroptosis-related genes could be a novel therapeutic target for focal segmental glomerulosclerosis, a recent study published in BMC...
Rare case of diabetic nephropathy with marked extra-capillary cell proliferation- A report Medha Baranwal23 May 2023 8:00 PM ISTJapan: A recent case study published in BMC Nephrology describes the rare case of finding extra-capillary hypercellularity in a patient with diabetic...
Investigational inaxaplin shows promise for race-linked kidney disease in phase 2a study Dr Kartikeya Kohli20 March 2023 10:30 AM ISTUSA: An investigation agent, Inaxaplin, was shown to substantially reduce proteinuria in patients with FSGS (focal segmental glomerulosclerosis) and...
Dapagliflozin improves kidney and cardiac function in cases of FSGS kidney disease: Study Hina Zahid10 Jun 2021 9:00 AM ISTSGLT2 inhibitors offer a promising new therapeutic option in the field of nephrology and are likely to be used more extensively in future, both in...
